24 | Chemokine CX3CL1IBA
05/2024
-
01/2004 |
15 | Monoclonal AntibodiesIBA
05/2024
-
12/2010 |
11 | ChemokinesIBA
08/2021
-
03/2004 |
10 | Drinking WaterIBA
01/2017
-
08/2003 |
10 | diisopropanolnitrosamineIBA
06/2012
-
03/2004 |
8 | quetmolimabIBA
01/2023
-
01/2018 |
7 | Proteins (Proteins, Gene)FDA Link
03/2023
-
06/2008 |
6 | CarcinogensIBA
07/2022
-
12/2002 |
6 | anthraceneIBA
10/2021
-
01/2005 |
6 | 9,10-Dimethyl-1,2-benzanthraceneIBA
05/2013
-
07/2002 |
6 | SulfadimethoxineIBA
06/2012
-
03/2004 |
5 | Codon (Codons)IBA
10/2021
-
09/2003 |
5 | nitrosobis(2-oxopropyl)amine (NBOP)IBA
10/2018
-
07/2010 |
5 | Messenger RNA (mRNA)IBA
01/2015
-
11/2004 |
5 | SDMIBA
06/2012
-
03/2004 |
4 | DNA (Deoxyribonucleic Acid)IBA
01/2023
-
10/2009 |
4 | Corn Oil (Oil, Corn)IBA
01/2023
-
04/2008 |
4 | AdipokinesIBA
10/2018
-
11/2011 |
4 | Indomethacin (Indometacin)FDA LinkGeneric
11/2012
-
06/2006 |
4 | Antithyroid Agents (Antithyroid Drugs)IBA
06/2012
-
03/2004 |
4 | Hydrogen Sulfide (Sulfide, Hydrogen)IBA
11/2010
-
12/2009 |
4 | sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2007
-
08/2003 |
4 | Dextrans (Dextran)FDA Link
10/2007
-
08/2003 |
3 | AcidsIBA
01/2023
-
05/2012 |
3 | IntegrinsIBA
01/2022
-
03/2011 |
3 | 2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
10/2021
-
01/2002 |
3 | LigandsIBA
05/2021
-
11/2002 |
3 | Cisplatin (Platino)FDA LinkGeneric
04/2020
-
01/2020 |
3 | AzoxymethaneIBA
01/2019
-
08/2011 |
3 | CX3C Chemokine Receptor 1IBA
11/2017
-
05/2005 |
3 | CytokinesIBA
07/2013
-
11/2002 |
3 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
03/2013
-
03/2007 |
3 | LeptinIBA
01/2012
-
08/2011 |
3 | Methylnitrosourea (N-Methyl-N-nitrosourea)IBA
02/2010
-
12/2005 |
3 | Capsules (Microcapsules)IBA
10/2009
-
03/2004 |
3 | 1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
10/2007
-
08/2003 |
3 | Dimenhydrinate (DMH)FDA LinkGeneric
10/2007
-
08/2003 |
2 | RNA (Ribonucleic Acid)IBA
05/2024
-
01/2021 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2024
-
01/2020 |
2 | GemcitabineFDA Link
10/2023
-
04/2020 |
2 | Antirheumatic Agents (DMARD)IBA
01/2023
-
07/2021 |
2 | Methotrexate (Mexate)FDA LinkGeneric
01/2023
-
01/2021 |
2 | Complement System Proteins (Complement)IBA
12/2022
-
07/2013 |
2 | CateninsIBA
07/2022
-
07/2013 |
2 | Phenobarbital (Luminal)FDA Link
10/2021
-
01/2021 |
2 | Estrogen ReceptorsIBA
10/2021
-
05/2013 |
2 | Transforming Growth Factor-beta Type II ReceptorIBA
01/2021
-
01/2020 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
01/2020
-
01/2020 |
2 | Tartrate-Resistant Acid PhosphataseIBA
01/2019
-
08/2009 |
2 | AminesIBA
05/2018
-
01/2002 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
08/2013
-
05/2012 |
2 | Urethane (Ethyl Carbamate)IBA
08/2013
-
11/2012 |
2 | cyclo(arginylglycyl)IBA
08/2013
-
05/2012 |
2 | Leptin ReceptorsIBA
05/2013
-
08/2011 |
2 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2013
-
01/2005 |
2 | nimesulide (Aulin)IBA
06/2012
-
02/2006 |
2 | Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2012
-
01/2005 |